CTKB - Cytek Biosciences, Inc.
IEX Last Trade
6.45
0 0%
Share volume: 16,101
Last Updated: Thu 26 Dec 2024 08:30:14 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$6.45
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-01 | 2023-05-09 | 2023-08-08 | 2023-11-14 | 2024-03-13 | 2024-05-08 | |
| Total revenue | 40.159 M | 40.477 M | 48.336 M | 37.088 M | 49.693 M | 48.000 M | 58.234 M | 44.860 M | |
| Cost of revenue | 15.598 M | 13.615 M | 18.962 M | 16.050 M | 21.531 M | 20.822 M | 25.186 M | 21.847 M | |
| Gross profit | 24.561 M | 26.862 M | 29.374 M | 21.038 M | 28.162 M | 27.178 M | 33.048 M | 23.013 M | |
| 9.37% | 9.35% | -28.38% | 33.86% | -3.49% | 21.60% | -30.36% | |||
| Operating expenses | 25.452 M | 25.502 M | 29.290 M | 33.200 M | 37.289 M | 33.598 M | 33.184 M | 33.747 M | |
| Selling general and admin | 17.016 M | 16.852 M | 19.543 M | 23.226 M | 25.153 M | 22.427 M | 22.314 M | 23.951 M | |
| Research and development | 8.436 M | 8.650 M | 9.747 M | 9.974 M | 12.136 M | 11.171 M | 10.870 M | 9.796 M | |
| Total expenses | 41.050 M | 39.117 M | 48.252 M | 49.250 M | 58.820 M | 54.420 M | 58.370 M | 55.594 M | |
| -4.71% | 23.35% | 2.07% | 19.43% | -7.48% | 7.26% | -4.76% | |||
| Operating income | -891.000 K | 1.360 M | 84.000 K | -12.162 M | -9.127 M | -6.420 M | -136.000 K | -10.734 M | |
| Ebit | -891.000 K | 1.360 M | 84.000 K | -12.162 M | -9.127 M | -6.420 M | -136.000 K | -10.734 M | |
| Pretax income | -1.401 M | 1.850 M | 4.114 M | -9.040 M | -6.595 M | -4.185 M | 4.111 M | -8.993 M | |
| -232.05% | 122.38% | -319.74% | -27.05% | -36.54% | -198.23% | -318.75% | |||
| Income tax | -699.000 K | 224.000 K | 396.000 K | -2.233 M | -2.207 M | 2.271 M | -1.392 M | -2.824 M | |
| Net income basic | -598.000 K | 1.626 M | 3.706 M | -6.807 M | -4.388 M | -6.456 M | 5.503 M | -6.169 M | |
| 371.91% | 127.92% | -283.68% | 35.54% | -47.13% | 185.24% | -212.10% | |||
| Net income | -598.000 K | 1.626 M | 3.706 M | -6.807 M | -4.388 M | -6.456 M | 5.503 M | -6.169 M | |
| 371.91% | 127.92% | -283.68% | 35.54% | -47.13% | 185.24% | -212.10% |